Pars Plana Vitrectomy with Internal Limiting Membrane peel
ProcedurePars plana vitrectomy with staining and peeling of internal limiting membrane
NCT Number: NCT04278079
Investigate the effectiveness and safety of pars plans vitrectomy, with internal limiting membrane peeling for cases of myopic traction maculopathy
Looking for future studies?
Notify Me30 year–60 year
All sexes
Interventional
Not applicable
Performing pars plana vitrectomy for highly myopic patients with decreased visual acuity is the standard of care for patients with myopic traction. A variety of findings are seen by Optical Coherence Tomography. Epiretinal membranes, retinoschisis, lamellar macular holes, and full thickness macular holes are seen. Undergoing vitrectomy, with or without tamponade, in our center, is retrospectively evaluated. Visual acuity change, as well as improvement of the retinal structure by OCT will be examined.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
At least 6 months follow-up
Exclusion criteria
Pars plana vitrectomy with staining and peeling of internal limiting membrane
Time frame: 6 months
Tanta University
Other
Evaluation of Pars Plana Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02528045
Macular Hole Retinal Detachment, Myopic Traction Maculopathy
Mitaka, Tokyo, Japan
View Trial DetailsNCT02528058
Myopic Traction Maculopathy
Mitaka, Tokyo, Japan
View Trial DetailsNCT06709378
Dislocated Lens, Eye Diseases
Changzhou, Jiangsu, China
View Trial DetailsNCT05013281
Disease, Pars Plana Vitrectomy
Beijing, Beijing Municipality, China
View Trial Details